ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to reform of tax code and possible timing of any such reform bill (no bill number yet)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW KAPLAN | — |
| BRADLEY ALLEN ROSSIN | — |
Copyright/Patent/Trademark CPT
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 - issues related to the development of antibiotics S. 214, HR 845, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Issues related to data exclusivity for patented biological products (No assigned legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| HEATHER STRAWN | — |
Health Issues HCR
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety and supply chain protections, including track and trace requirements (No assigned legislation)Issues related to federal purchases under the Trade Agreements Act Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits Issues related to patient adherence to prescribed medication therapies (No assigned legislation) Issues related to oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program S. 264 (Excellence in Mental Health Act), S. 153 (Mental Health First Aid Act) issues related to mental health and pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| HEATHER STRAWN | — |
Trade (domestic/foreign) TRD
Issues related to trade protections in Trans Pacific Partnership Issues related to trade liberalization between US and European Union
Foreign entity interest: AstraZeneca PLC, identified in our LDA Registration information, distributes and sells patented pharmaceutical products globally and would benefit from strengthened global intellectual property rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Medicare/Medicaid MMM
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration Issues related to the Medicaid rebate formula and applicability Issues related to possible imposition of rebates for Medicare Part B drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| HEATHER STRAWN | — |
Consumer Issues/Safety/Products CSP
Issues related to drug safety and supply chain protections (No assigned legislation) Issues related to importation of pharmaceutical products from foreign countries (No assigned legislation) Issues related to patient adherence to prescribed medication therapies (No assigned legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| BELA SASTRY | — |
| HEATHER STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.